Search

everythinglearnresearchcommunity

for

Search:↓

Robotic surgery in plastic and reconstructive procedures improves precision and outcomes but faces challenges like high costs and long operating times.

Robotic systems in cosmetic surgery show promise but face challenges like high costs and need more research and training.

Robotic systems in cosmetic surgery are promising but need more development and research.

Adipose-derived stem cells are promising for tissue and organ repair due to their easy access and versatility.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib helps patients with severe alopecia areata regrow hair.

The shampoo with Urtica urens L. extract reduced hair loss and didn't irritate the skin.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Human foreskin fibroblast–conditioned medium improved hair growth in androgenetic alopecia patients.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Autosomal recessive woolly hair is rare and involves tightly coiled hair without other health issues.

Human hair follicle stem cells improved memory and brain health in rats.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Visual signs are crucial for accurately diagnosing and treating different types of hair loss in Black patients.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib effectively treats severe alopecia for up to 104 weeks.